Follow the latest coverage, related explainers and connected technology stories.
Intero Biosystems sells laboratory-grown organoid models of human intestines to pharmaceutical and biotechnology companies, aiming to provide a model closer to human biology and use it alongside or, in some cases, instead of animal testing. The company is still in the second of three stages for proving GastroScreen’s ability to predict drug responses in humans.